Primary Immune Thrombocytopenia – ITP

Primary Immune Thrombocytopenia

Study code: 20-003
£3,800

People with Primary Immune Thrombocytopenia needed for the study of a potential new medicine for treating ITP. You must be aged 18 to 55 and must have been diagnosed at least 3 months ago. The study involves 2 screening visits, 8 nights’ residence and 7 outpatient visits, over approximately two and a half months.